🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

McKesson share price target raised by TD Cowen on strong FY25 outlook

EditorEmilio Ghigini
Published 08/05/2024, 15:48
MCK
-

On Wednesday, TD Cowen adjusted its outlook on McKesson Corporation (NYSE: NYSE:MCK), raising the share price target to $652 from the previous $563, while reiterating a Buy rating on the stock.

The firm's optimism is driven by McKesson's robust fiscal year 2025 guidance, which includes adjusted earnings per share (EPS) projections ranging between $31.25 and $32.05. This forecast surpasses the consensus estimate of $31.09.

The firm expressed confidence in McKesson's potential for sustained momentum within its core businesses. Additionally, TD Cowen highlighted the company's capability to capitalize on distinct growth opportunities.

Among these opportunities is the recent contract win with Optum and the potential expansion of GLP-1 treatments through McKesson's CoverMyMeds platform.

TD Cowen's revised forecast for McKesson's fiscal year 2025 adjusted EPS stands at $31.62, a slight increase from the previous estimate of $31.35.

McKesson has been identified as a top pick for 2024 by the firm, underscoring the belief in the company's strong market position and future prospects. The raised price target and maintained Buy rating signal TD Cowen's confidence in McKesson's ability to perform well in the upcoming fiscal years.

InvestingPro Insights

As McKesson Corporation (NYSE: MCK) continues to make headlines with its promising fiscal year 2025 guidance, the InvestingPro platform offers additional insights into the company's financial health and market performance. With a robust market capitalization of $72.27 billion and a P/E ratio of 24.48, McKesson showcases stability in the healthcare sector. Notably, the company has demonstrated a commitment to shareholder returns, with an impressive track record of raising its dividend for 16 consecutive years, and maintaining dividend payments for 31 consecutive years, reflecting a consistent and reliable income stream for investors.

InvestingPro Tips for McKesson highlight the company's strategic share repurchases and its status as a prominent player in the Healthcare Providers & Services industry. Additionally, the platform notes that McKesson operates with a moderate level of debt and its cash flows can sufficiently cover interest payments, suggesting a prudent financial management strategy. For investors seeking detailed analysis and further tips on McKesson, the InvestingPro platform lists 15 additional tips that could provide deeper insights into the company's performance and potential investment opportunities.

Interested readers can explore these insights and more by taking advantage of a special offer: use coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription at https://www.investing.com/pro/MCK. This offer brings exclusive access to real-time data, analytics, and expert opinions that could enhance investment strategies in a dynamic market landscape.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.